Investigating racial disparities in drug prescriptions for patients with endometriosis
Abstract We assess racial disparities in medication prescription patterns for endometriosis patients across Medicaid administrative claims data. We use ATC 3rd level drug codes to identify drug classes prescribed significantly more frequently for endometriosis patients than a comparison cohort of no...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | npj Women's Health |
| Online Access: | https://doi.org/10.1038/s44294-025-00053-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832571181181435904 |
|---|---|
| author | Aparajita Kashyap Maryam Aziz Tony Y Sun Sharon Lipsky Gorman Jessica Opoku-Anane Noémie Elhadad |
| author_facet | Aparajita Kashyap Maryam Aziz Tony Y Sun Sharon Lipsky Gorman Jessica Opoku-Anane Noémie Elhadad |
| author_sort | Aparajita Kashyap |
| collection | DOAJ |
| description | Abstract We assess racial disparities in medication prescription patterns for endometriosis patients across Medicaid administrative claims data. We use ATC 3rd level drug codes to identify drug classes prescribed significantly more frequently for endometriosis patients than a comparison cohort of non-endometriosis patients. Temporal prevalence differences of prescriptions (pre- vs. post-diagnosis) were also examined. The endometriosis cohort comprised 16,372 endometriosis patients (23.3% Black, 66.0% White). Of the 28 drug classes examined, 17 were prescribed significantly less in Black patients and 4 were prescribed significantly more in Black patients. Of the 17 drugs prescribed more often in White patients, 13 have larger disparities pre-diagnosis than post-diagnosis. In the non-endometriosis cohort (n = 3,663,904), 21 drug classes were prescribed significantly more in White patients and 6 were prescribed significantly more in Black patients. Our analysis identifies disparities in prescriptions practices between White and Black endometriosis patients, notably in pain management and comorbidity treatment. |
| format | Article |
| id | doaj-art-8aebc5ab7618402ebc08f13bd973de96 |
| institution | Kabale University |
| issn | 2948-1716 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | npj Women's Health |
| spelling | doaj-art-8aebc5ab7618402ebc08f13bd973de962025-02-02T12:48:29ZengNature Portfolionpj Women's Health2948-17162025-01-01311710.1038/s44294-025-00053-3Investigating racial disparities in drug prescriptions for patients with endometriosisAparajita Kashyap0Maryam Aziz1Tony Y Sun2Sharon Lipsky Gorman3Jessica Opoku-Anane4Noémie Elhadad5Columbia University Irving Medical Center, Department of Biomedical InformaticsColumbia University, Department of Computer ScienceColumbia University Irving Medical Center, Department of Biomedical InformaticsColumbia University Irving Medical Center, Department of Biomedical InformaticsRutgers Robert Wood Johnson Medical School, Department of Obstetrics and GynecologyColumbia University Irving Medical Center, Department of Biomedical InformaticsAbstract We assess racial disparities in medication prescription patterns for endometriosis patients across Medicaid administrative claims data. We use ATC 3rd level drug codes to identify drug classes prescribed significantly more frequently for endometriosis patients than a comparison cohort of non-endometriosis patients. Temporal prevalence differences of prescriptions (pre- vs. post-diagnosis) were also examined. The endometriosis cohort comprised 16,372 endometriosis patients (23.3% Black, 66.0% White). Of the 28 drug classes examined, 17 were prescribed significantly less in Black patients and 4 were prescribed significantly more in Black patients. Of the 17 drugs prescribed more often in White patients, 13 have larger disparities pre-diagnosis than post-diagnosis. In the non-endometriosis cohort (n = 3,663,904), 21 drug classes were prescribed significantly more in White patients and 6 were prescribed significantly more in Black patients. Our analysis identifies disparities in prescriptions practices between White and Black endometriosis patients, notably in pain management and comorbidity treatment.https://doi.org/10.1038/s44294-025-00053-3 |
| spellingShingle | Aparajita Kashyap Maryam Aziz Tony Y Sun Sharon Lipsky Gorman Jessica Opoku-Anane Noémie Elhadad Investigating racial disparities in drug prescriptions for patients with endometriosis npj Women's Health |
| title | Investigating racial disparities in drug prescriptions for patients with endometriosis |
| title_full | Investigating racial disparities in drug prescriptions for patients with endometriosis |
| title_fullStr | Investigating racial disparities in drug prescriptions for patients with endometriosis |
| title_full_unstemmed | Investigating racial disparities in drug prescriptions for patients with endometriosis |
| title_short | Investigating racial disparities in drug prescriptions for patients with endometriosis |
| title_sort | investigating racial disparities in drug prescriptions for patients with endometriosis |
| url | https://doi.org/10.1038/s44294-025-00053-3 |
| work_keys_str_mv | AT aparajitakashyap investigatingracialdisparitiesindrugprescriptionsforpatientswithendometriosis AT maryamaziz investigatingracialdisparitiesindrugprescriptionsforpatientswithendometriosis AT tonyysun investigatingracialdisparitiesindrugprescriptionsforpatientswithendometriosis AT sharonlipskygorman investigatingracialdisparitiesindrugprescriptionsforpatientswithendometriosis AT jessicaopokuanane investigatingracialdisparitiesindrugprescriptionsforpatientswithendometriosis AT noemieelhadad investigatingracialdisparitiesindrugprescriptionsforpatientswithendometriosis |